List of insiders holdings for CRISPR Therapeutics AG:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | GLAXOSMITHKLINE PLC 10% Owner |
2020-07-10 17:26:33 | 3,310,627 0 |
3,310,627 | Form 13D |
| 2 | BAYER AKTIENGESELLSCHAFT Bayer Global Investments B.V. 10% Owner |
2020-02-04 16:19:06 | 2,954,775 0 |
2,954,775 | Form 13D |
| 3 | CELGENE CORP 10% Owner |
2018-02-08 16:25:56 | 2,800,772 0 |
2,800,772 | Form 13D |
| 4 | Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner |
2020-02-13 16:05:28 | 2,690,470 0 |
2,690,470 | Form 13G |
| 5 | Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP Versant Ventures IV LLC Versant Ventures V LLC Versant Ventures V (Canada) L.P. 10% Owner |
2021-02-16 07:33:52 | 1,344,010 0 |
1,344,010 | Form 13D |
| 6 | Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Ventures IV LLC Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP 10% Owner |
2021-02-16 07:33:52 | 1,344,010 0 |
1,344,010 | Form 13D |
| 7 | EMSTER KURT VON Director |
2019-01-18 16:32:23 | 0 1,171,268 |
1,171,268 | Form 4/A |
| 8 | Lundberg Sven Ante Chief Scientific Officer |
2017-02-10 14:16:28 | 505,217 505,617 |
1,010,834 | Form 4 |
| 9 | Hadley Harbor Master Investors (Cayman) L.P. 10% Owner |
2016-10-24 14:58:09 | 744,380 0 |
744,380 | Form 4 |
| 10 | Novak Rodger President |
2021-07-01 17:43:55 | 573,007 0 |
573,007 | Form 4 |
| 11 | Kulkarni Samarth Chief Executive Officer |
2025-03-24 17:35:09 | 254,147 85,622 |
339,769 | Form 4 |
| 12 | TOMSICEK MICHAEL JOHN Chief Financial Officer |
2021-08-10 20:00:31 | 132,891 0 |
132,891 | Form 4 |
| 13 | Versant Venture Capital V L.P. Versant Ventures V LLC Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP 10% Owner |
2018-04-26 16:44:03 | 0 115,645 |
115,645 | Form 4 |
| 14 | KASINGER JAMES R. General Counsel and Secretary |
2025-03-24 17:35:04 | 100,479 0 |
100,479 | Form 4 |
| 15 | Subramanian Kala See Remarks |
2017-06-19 16:05:33 | 85,000 0 |
85,000 | Form 4 |
| 16 | Patel Naimish Chief Medical Officer |
2025-03-18 17:35:08 | 79,167 0 |
79,167 | Form 4 |
| 17 | Dylan-Hyde Tyler Chief Legal Officer |
2018-01-18 17:38:36 | 67,104 0 |
67,104 | Form 4 |
| 18 | Ho Tony W Executive VP, Head of R&D |
2021-12-07 20:00:19 | 65,697 0 |
65,697 | Form 4 |
| 19 | CAGNONI PABLO J Director |
2019-11-21 16:07:43 | 63,833 0 |
63,833 | Form 4 |
| 20 | Prasad Raju Chief Financial Officer |
2025-03-24 17:35:06 | 35,517 0 |
35,517 | Form 4 |
| 21 | Woiwode Thomas Director |
2018-06-15 21:39:45 | 0 30,000 |
30,000 | Form 4 |
| 22 | Bruno Julianne Chief Operating Officer |
2025-03-24 17:35:07 | 21,794 7,088 |
28,882 | Form 4 |
| 23 | Rommel Christian Director |
2024-05-31 16:15:05 | 26,000 0 |
26,000 | Form 4 |
| 24 | Morrow Phuong Khanh Chief Medical Officer |
2023-10-17 17:52:27 | 16,667 0 |
16,667 | Form 4 |
| 25 | Smith Brendan Chief Financial Officer |
2023-02-22 17:41:41 | 16,547 0 |
16,547 | Form 4 |
| 26 | COLES N ANTHONY Director |
2017-06-02 16:30:19 | 15,000 0 |
15,000 | Form 4 |
| 27 | Mahatme Sandesh Director |
2024-05-31 16:15:06 | 13,000 0 |
13,000 | Form 4 |
| 28 | Fardis Maria Director |
2024-05-31 16:15:06 | 13,000 0 |
13,000 | Form 4 |
| 29 | Behbahani Ali Director |
2024-05-31 16:50:04 | 13,000 0 |
13,000 | Form 4 |
| 30 | George Simeon Director |
2024-05-31 16:50:29 | 13,000 0 |
13,000 | Form 4 |
| 31 | High Katherine A Director |
2024-05-31 16:15:04 | 13,000 0 |
13,000 | Form 4 |
| 32 | Treco Douglas A Director |
2024-05-31 16:15:03 | 13,000 0 |
13,000 | Form 4 |
| 33 | Fleming Harold Edward Director |
2024-05-31 16:15:03 | 13,000 0 |
13,000 | Form 4 |
| 34 | Klein Lawrence Otto CBO & COO |
2022-08-18 17:36:02 | 12,500 0 |
12,500 | Form 4 |
| 35 | Bolzon Bradley J PhD Director |
2022-06-10 17:35:09 | 12,000 0 |
12,000 | Form 4 |
| 36 | Greene John Director |
2025-02-28 17:35:05 | 7,000 0 |
7,000 | Form 4 |